Vanda Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	84.85	102.32	135.82	135.03	52.07
Short-Term Investments	179	272.33	252.44	331.83	380.74
Cash & Short-Term Investments	263.85	374.64	388.26	466.86	432.81
Cash Growth	-29.57%	-3.51%	-16.84%	7.87%	17.70%
Receivables	54.58	47.1	34.16	33.51	32.47
Inventory	1.85	1.73	1.36	1.19	1.03
Prepaid Expenses	26.99	15.42	9.17	6.23	12
Other Current Assets	-	-	-	11.5	-
Total Current Assets	347.26	438.89	432.95	519.29	478.3
Property, Plant & Equipment	13.51	12.68	9.14	10.97	12.39
Other Intangible Assets	117.09	114.1	121.37	18.57	20.08
Long-Term Deferred Tax Assets	-	81.44	75	74.04	74.88
Other Long-Term Assets	11.08	9.1	9.99	11.38	8.15
Total Assets	488.95	656.2	648.44	634.25	593.79
Accounts Payable	68.3	3.5	7.15	12.69	0.93
Accrued Expenses	-	31.32	28.92	30.53	31.2
Current Portion of Leases	-	4.27	2.4	2.33	2.31
Other Current Liabilities	76.87	60.9	49.24	45.89	39.98
Total Current Liabilities	145.16	99.98	87.7	91.44	74.42
Long-Term Leases	7.07	8.09	7.01	8.81	10.06
Other Long-Term Liabilities	9.53	9.59	8.83	6.8	4.39
Total Liabilities	161.76	117.66	103.53	107.05	88.86
Common Stock	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	721.26	712.71	700.27	686.24	669.22
Retained Earnings	-394.77	-174.29	-155.39	-157.9	-164.18
Comprehensive Income & Other	0.63	0.07	-0.03	-1.19	-0.18
Shareholders' Equity	327.19	538.55	544.91	527.2	504.93
Total Liabilities & Equity	488.95	656.2	648.44	634.25	593.79
Total Debt	7.07	12.36	9.4	11.14	12.37
Net Cash (Debt)	256.78	362.28	378.86	455.72	420.45
Net Cash Growth	-29.12%	-4.38%	-16.86%	8.39%	18.73%
Net Cash Per Share	4.36	6.23	6.58	8.00	7.39
Filing Date Shares Outstanding	59.1	58.32	57.54	56.79	55.91
Total Common Shares Outstanding	59.1	58.31	57.53	56.78	55.9
Working Capital	202.1	338.91	345.25	427.86	403.88
Book Value Per Share	5.54	9.24	9.47	9.28	9.03
Tangible Book Value	210.1	424.45	423.54	508.63	484.85
Tangible Book Value Per Share	3.56	7.28	7.36	8.96	8.67
Machinery	-	8.23	7.78	7.58	7.03
Leasehold Improvements	-	5.47	5.44	5.42	5.46

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q